This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Talk:Antidepressants: Difference between revisions
>Unity Added Pharmaceutical category |
>Unity New markup standard for literature references e.g. '''''Title of Paper''''' It's bolded and italicized with 5 ' marks. (do NOT do this for normal references) |
||
| Line 2: | Line 2: | ||
'''Antidepressants''' commonly refers to family of pharmaceutical agents used in modern medicine for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive-compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), dependence/addiction, and sleep disorders. They may be prescribed alone or in combination with other medications.{{citation needed}} | '''Antidepressants''' commonly refers to family of pharmaceutical agents used in modern medicine for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive-compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), dependence/addiction, and sleep disorders. They may be prescribed alone or in combination with other medications.{{citation needed}} | ||
The major classes of antidepressants are the [[selective serotonin reuptake inhibitor]]s ('''SSRIs'''), [[serotonin–norepinephrine reuptake inhibitors]] ('''SNRIs'''), [[MAOI|monoamine oxidase inhibitors]] ('''MAOIs'''), reversible monoamine oxidase A inhibitors ('''rMAO-A inhibitors'''), tetracyclic antidepressants ('''TeCAs'''), and noradrenergic and specific serotonergic antidepressant ('''NaSSAs'''). Herbal substances such as | The major classes of antidepressants are the [[selective serotonin reuptake inhibitor]]s ('''SSRIs'''), [[serotonin–norepinephrine reuptake inhibitors]] ('''SNRIs'''), [[MAOI|monoamine oxidase inhibitors]] ('''MAOIs'''), reversible monoamine oxidase A inhibitors ('''rMAO-A inhibitors'''), tetracyclic antidepressants ('''TeCAs'''), and noradrenergic and specific serotonergic antidepressant ('''NaSSAs'''). Herbal substances such as ''St. John's wort'' is also sometimes used in the treatment of depression<ref>Linde, K., Kriston, L., Rucker, G., Jamil, S., Schumann, I., Meissner, K., . . . Schneider, A. (2015). Efficacy and Acceptability of Pharmacological Treatments for Depressive Disorders in Primary Care: Systematic Review and Network Meta-Analysis. ''The Annals of Family Medicine'', 13(1), 69-79. doi:10.1370/afm.1687</ref><ref>Linde, K., Berner, M. M., & Kriston, L. (2008). St John's wort for major depression. ''Cochrane Database of Systematic Reviews''. doi:10.1002/14651858.cd000448.pub3</ref> | ||
== Clinical Guidelines for Diagnosis and Prescription == | == Clinical Guidelines for Diagnosis and Prescription == | ||
| Line 65: | Line 65: | ||
==See Also== | ==See Also== | ||
*[[Antipsychotics]] | *[[Antipsychotics]] | ||
==Literature== | ==Literature== | ||
* Linde, K., Kriston, L., Rucker, G., Jamil, S., Schumann, I., Meissner, K., . . . Schneider, A. (2015). | * Linde, K., Kriston, L., Rucker, G., Jamil, S., Schumann, I., Meissner, K., . . . Schneider, A. (2015). '''''Efficacy and Acceptability of Pharmacological Treatments for Depressive Disorders in Primary Care: Systematic Review and Network Meta-Analysis.''''' ''The Annals of Family Medicine'', 13(1), 69-79. doi:10.1370/afm.1687 | ||
==References== | ==References== | ||